iSERA Lifesciences Limited declared the voting results for its 34th Annual General Meeting (AGM) held on September 29, 2026. Shareholders approved all proposed resolutions, including the adoption of FY26 financial statements and the reappointment of Jitendra Prabhakar Nene as a director.

The meeting was chaired by Jayshree Suresh Jain, Managing Director, and held via video conferencing from the registered office in Pune. A total of 47 members attended the session, which commenced at 3:00 pm and concluded at 3:20 pm. The company facilitated remote e-voting pursuant to Section 108 of the Companies Act, 2013, with the voting window opening on September 26, 2026, at 9:00 am and closing on September 28, 2026, at 5:00 pm.

Key resolutions passed

The shareholders approved the following ordinary business items through e-voting:

1. Adoption of the audited balance sheet, statement of profit and loss, and cash flow statement for FY26, along with the Board's Report and Statutory Auditor's Report.
2. Re-appointment of Jitendra Prabhakar Nene (DIN: 06814833) as a director liable to retire by rotation.

Both items were passed by ordinary resolution with a requisite majority. The Chairman provided an overview of the company's performance and future outlook, allowing members to seek clarifications on agenda items.

Voting process details

Anuj Gupta, a Company Secretary in whole-time practice, served as the scrutinizer for the e-voting process. The facility was managed by MUFG Intime India Private Limited in compliance with Regulation 44 of the SEBI (LODR) Regulations, 2015. During the AGM, members who had not voted remotely were permitted to cast their votes electronically until 15 minutes after the meeting's conclusion.

Voting results summary

The consolidated results of remote e-voting and e-voting at the AGM confirmed that both resolutions were passed unanimously among those who voted. No votes were recorded against either resolution.

The total number of valid votes cast was 781,837, representing approximately 9.3% of the total outstanding shares. Promoters and promoter group did not cast any votes during the remote e-voting or at the AGM. All votes were cast by public non-institutional shareholders.

iSERA Lifesciences has scheduled its 34th Annual General Meeting (AGM) for September 29, 2026. The meeting will be held via video conference to adopt financial statements for FY26 and consider the reappointment of a retiring director.

The Board of Directors approved the notice and key resolutions during a meeting held on September 1, 2026. The company also finalized the appointment of M/s. Anuj Gupta & Associates as the scrutinizer for the voting process.

Key Agenda Items

The AGM will transact the following ordinary business:

• Adoption of the audited standalone financial statements for the financial year ended March 31, 2026.
• Reappointment of Mr. Jitendra Prabhakar Nene (DIN: 06814833), who retires by rotation at this meeting and is eligible for reappointment.

Voting and Logistics

The meeting will be conducted through Video Conferencing or Other Audio-Visual Means (OAVM) in compliance with MCA and SEBI regulations. Physical attendance is not permitted.

Members holding shares in demat form as on the cut-off date of September 22, 2026, are eligible to vote. Remote e-voting will commence on September 26, 2026, at 9:00 am and end on September 28, 2026, at 5:00 pm.